ReviewFrontiers in immunology2022

How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?

Ghislain Opdenakker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.